Home>Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer
Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer
- Impact factors: 8.039
- Publication: JOURNAL OF MEDICINAL CHEMISTRY
- Author:Lin Ma, Yingying Li, Ruixiang Luo, Yuhan Wang, Jiaqi Cao, Weitao Fu, Bolan Qian, Lei Zheng, Longguang Tang, Xinting Lv, Lulu Zheng, Guang Liang, Lingfeng Chen
- DOI citation-doi:10.1021/acs.jmedchem.3c00150
- Date:2023-05-23